CHEMED CORPORATION (CHE) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 106.49×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | 106.49× | Operating income ÷ reported interest expense. $349.19M ÷ $3.28M ≈ 106.49× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.60B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 349.19M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 3.28M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.60B | (m) | $349.19M | $3.28M | (m) | (m) | 106.49× | Reported |
| 2026-03-31 | (m) | $2.54B | (m) | $328.07M | $1.93M | (m) | (m) | 169.72× | Reported |
| 2025-12-31 | (m) | $2.53B | (m) | $338.25M | $1.75M | (m) | (m) | 193.28× | Reported |
| 2025-09-30 | (m) | $2.30B | (m) | $351.47M | $1.73M | (m) | (m) | 203.40× | Reported |
| 2025-06-30 | (m) | $2.07B | (m) | $368.88M | $1.70M | (m) | (m) | 217.24× | Reported |
| 2025-03-31 | (m) | $1.82B | (m) | $388.92M | $1.68M | (m) | (m) | 230.95× | Reported |
| 2024-12-31 | (m) | $1.53B | (m) | $366.49M | $1.78M | (m) | (m) | 205.89× | Reported |
| 2024-09-30 | (m) | $1.47B | (m) | $364.01M | $1.62M | (m) | (m) | 224.28× | Reported |
| 2024-06-30 | (m) | $1.41B | (m) | $358.70M | $1.64M | (m) | (m) | 218.72× | Reported |
| 2024-03-31 | (m) | $1.36B | (m) | $340.08M | $1.98M | (m) | (m) | 171.59× | Reported |
| 2023-12-31 | (m) | $1.32B | (m) | $340.57M | $3.11M | (m) | (m) | 109.58× | Reported |
| 2023-09-30 | (m) | $1.27B | (m) | $310.50M | $4.37M | (m) | (m) | 71.10× | Reported |
| 2023-06-30 | (m) | $1.24B | (m) | $304.51M | $5.19M | (m) | (m) | 58.63× | Reported |
| 2023-03-31 | (m) | $1.21B | (m) | $326.94M | $5.33M | (m) | (m) | 61.40× | Reported |
| 2022-12-31 | (m) | $1.20B | (m) | $343.50M | $4.58M | (m) | (m) | 74.93× | Reported |
| 2022-09-30 | (m) | $1.21B | (m) | $360.20M | $3.51M | (m) | (m) | 102.68× | Reported |
| 2022-06-30 | (m) | $1.23B | (m) | $372.21M | $2.82M | (m) | (m) | 131.99× | Reported |
| 2022-03-31 | (m) | $1.24B | (m) | $351.97M | $2.30M | (m) | (m) | 153.23× | Reported |
| 2021-12-31 | (m) | $1.26B | (m) | $343.04M | $1.87M | (m) | (m) | 183.64× | Reported |
| 2021-09-30 | (m) | $1.39B | (m) | $388.26M | $1.69M | (m) | (m) | 229.33× | Reported |
| 2021-06-30 | (m) | $1.38B | (m) | $369.70M | $1.49M | (m) | (m) | 248.29× | Reported |
| 2021-03-31 | (m) | $1.35B | (m) | $390.76M | $1.76M | (m) | (m) | 221.90× | Reported |
| 2020-12-31 | (m) | $1.33B | (m) | $389.68M | $2.35M | (m) | (m) | 165.47× | Reported |
| 2020-09-30 | (m) | $1.41B | (m) | $323.88M | $3.14M | (m) | (m) | 103.21× | Reported |
| 2020-06-30 | (m) | $1.36B | (m) | $314.50M | $3.80M | (m) | (m) | 82.76× | Reported |
| 2020-03-31 | (m) | $1.33B | (m) | $287.27M | $4.39M | (m) | (m) | 65.50× | Reported |
| 2019-12-31 | (m) | $1.28B | (m) | $257.38M | $4.54M | (m) | (m) | 56.75× | Reported |
| 2019-09-30 | (m) | $1.29B | (m) | $247.31M | $4.58M | (m) | (m) | 54.01× | Reported |
| 2019-06-30 | (m) | $1.25B | (m) | $244.09M | $4.62M | (m) | (m) | 52.83× | Reported |
| 2019-03-31 | (m) | $1.22B | (m) | $236.71M | $4.91M | (m) | (m) | 48.24× | Reported |
| 2018-12-31 | (m) | $1.20B | (m) | $243.63M | $4.99M | (m) | (m) | 48.82× | Reported |
| 2018-09-30 | (m) | $1.75B | (m) | $232.78M | $4.92M | (m) | (m) | 47.30× | Reported |
| 2018-06-30 | (m) | $1.73B | (m) | $225.07M | $4.89M | (m) | (m) | 46.05× | Reported |
| 2018-03-31 | (m) | $1.70B | (m) | $127.98M | $4.48M | (m) | (m) | 28.54× | Reported |
| 2017-12-31 | (m) | $1.67B | (m) | $113.03M | $4.27M | (m) | (m) | 26.46× | Reported |
| 2017-09-30 | (m) | $1.64B | (m) | $109.63M | $4.05M | (m) | (m) | 27.08× | Reported |
| 2017-06-30 | (m) | $1.62B | (m) | $98.50M | $4.02M | (m) | (m) | 24.51× | Reported |
| 2017-03-31 | (m) | $1.59B | (m) | $175.81M | $3.87M | (m) | (m) | 45.45× | Reported |
| 2016-12-31 | (m) | $1.58B | (m) | $178.75M | $3.71M | (m) | (m) | 48.12× | Reported |
| 2016-09-30 | (m) | $1.57B | (m) | $174.79M | $3.63M | (m) | (m) | 48.15× | Reported |
| 2016-06-30 | (m) | $1.57B | (m) | $182.04M | $3.52M | (m) | (m) | 51.72× | Reported |
| 2016-03-31 | (m) | $1.56B | (m) | $188.28M | $3.52M | (m) | (m) | 53.52× | Reported |
| 2015-12-31 | (m) | $1.54B | (m) | $184.46M | $3.65M | (m) | (m) | 50.61× | Reported |
| 2015-09-30 | (m) | $1.52B | (m) | $185.34M | $3.81M | (m) | (m) | 48.67× | Reported |
| 2015-06-30 | (m) | $1.50B | (m) | $175.42M | $3.88M | (m) | (m) | 45.21× | Reported |
| 2015-03-31 | (m) | $1.47B | (m) | $172.34M | $5.34M | (m) | (m) | 32.27× | Reported |
| 2014-12-31 | (m) | $1.46B | (m) | $168.42M | $8.19M | (m) | (m) | 20.57× | Reported |
| 2014-09-30 | (m) | $1.43B | (m) | $157.82M | $10.97M | (m) | (m) | 14.39× | Reported |
| 2014-06-30 | (m) | $1.41B | (m) | $146.82M | $13.49M | (m) | (m) | 10.89× | Reported |
| 2014-03-31 | (m) | $1.40B | (m) | $131.19M | $14.76M | (m) | (m) | 8.89× | Reported |
| 2013-12-31 | (m) | $1.41B | (m) | $133.39M | $15.04M | (m) | (m) | 8.87× | Reported |
| 2013-09-30 | (m) | $1.43B | (m) | $139.90M | $14.98M | (m) | (m) | 9.34× | Reported |
| 2013-06-30 | (m) | $1.45B | (m) | $146.66M | $15.22M | (m) | (m) | 9.63× | Reported |
| 2013-03-31 | (m) | $1.44B | (m) | $160.29M | $15.20M | (m) | (m) | 10.55× | Reported |
| 2012-12-31 | (m) | $1.43B | (m) | $156.42M | $14.72M | (m) | (m) | 10.62× | Reported |
| 2012-09-30 | (m) | $1.41B | (m) | $156.50M | $14.66M | (m) | (m) | 10.68× | Reported |
| 2012-06-30 | (m) | $1.40B | (m) | $161.84M | $14.47M | (m) | (m) | 11.18× | Reported |
| 2012-03-31 | (m) | $1.38B | (m) | $158.16M | $14.26M | (m) | (m) | 11.09× | Reported |
| 2011-12-31 | (m) | $1.36B | (m) | $153.73M | $13.89M | (m) | (m) | 11.07× | Reported |
| 2011-09-30 | (m) | $1.34B | (m) | $146.17M | $13.27M | (m) | (m) | 11.01× | Reported |
| 2011-06-30 | (m) | $1.32B | (m) | $141.61M | $12.71M | (m) | (m) | 11.14× | Reported |
| 2011-03-31 | (m) | $1.30B | (m) | $139.63M | $12.25M | (m) | (m) | 11.40× | Reported |
| 2010-12-31 | (m) | $1.28B | (m) | $143.52M | $11.96M | (m) | (m) | 12.00× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.19B | (m) | $126.34M | $11.60M | (m) | (m) | 10.89× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.15B | (m) | $132.86M | $12.12M | (m) | (m) | 10.96× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |